{"id":19379,"date":"2025-04-23T09:35:43","date_gmt":"2025-04-23T07:35:43","guid":{"rendered":"https:\/\/bio4dreams.com\/?p=19379"},"modified":"2025-04-23T09:35:45","modified_gmt":"2025-04-23T07:35:45","slug":"investment-cp2biotech-startup-immunomodulatory-therapies","status":"publish","type":"post","link":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/","title":{"rendered":"Bio4Dreams invests in CP2 Biotech"},"content":{"rendered":"\n<p><strong><a href=\"https:\/\/bio4dreams.com\/en\/startup-cp2biotech-immunotherapy-inflammation\/\">CP2 Biotech<\/a><\/strong>, a startup incubated by Bio4Dreams since 2024 and specialized in developing therapeutic solutions to modulate immune and inflammatory processes, <strong>has received an investment from Bio4Dreams<\/strong> to accelerate the preclinical development and validation of its innovative molecules.<\/p>\n\n\n\n<p>Founded in 2020 as a spin-off of the University of Milano-Bicocca, <strong>CP2 Biotech<\/strong> focuses on <strong>researching and developing molecules<\/strong> capable of modulating the activity of the TLR4 receptor\u2014a key component in <strong>regulating the body\u2019s immune and inflammatory responses<\/strong>. These solutions represent potential breakthrough treatments for serious conditions such as autoimmune, fibrotic, and oncological diseases.<\/p>\n\n\n\n<p><strong>This investment<\/strong> builds on the ongoing support provided through the startup\u2019s incubation and aims to <strong>fast-track<\/strong> the most promising CP2 Biotech <strong>molecules toward clinical trials<\/strong>.<\/p>\n\n\n\n<p>Thanks to the investment and the access to Bio4Dreams\u2019 international network, CP2 Biotech is now better positioned to strengthen its operations and accelerate molecule validation\u2014bringing its <strong>research one step closer to becoming real, life-changing therapies for patients<\/strong>.<\/p>\n\n\n\n<p>\ud83d\udcd7 Learn more about <strong>CP2 Biotech<\/strong> and other companies in <a href=\"https:\/\/bio4dreams.com\/en\/portfolio\/\">our portfolio<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.<\/p>\n","protected":false},"author":8,"featured_media":19384,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1313],"tags":[1309],"class_list":["post-19379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-portfolio","tag-highlights-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bio4Dreams invests in CP2 Biotech - Bio4Dreams<\/title>\n<meta name=\"description\" content=\"An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio4Dreams invests in CP2 Biotech - Bio4Dreams\" \/>\n<meta property=\"og:description\" content=\"An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Bio4Dreams\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Bio4Dreams\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-23T07:35:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-23T07:35:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bio4dreams.com\/wp-content\/uploads\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bio4Dreams | NS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bio4dreams\" \/>\n<meta name=\"twitter:site\" content=\"@bio4dreams\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bio4Dreams | NS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/\"},\"author\":{\"name\":\"Bio4Dreams | NS\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/person\\\/9af11b6db87fca29131e5095f3b0e452\"},\"headline\":\"Bio4Dreams invests in CP2 Biotech\",\"datePublished\":\"2025-04-23T07:35:43+00:00\",\"dateModified\":\"2025-04-23T07:35:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/\"},\"wordCount\":176,\"publisher\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg\",\"keywords\":[\"Highlights\"],\"articleSection\":[\"Portfolio\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/\",\"name\":\"Bio4Dreams invests in CP2 Biotech - Bio4Dreams\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg\",\"datePublished\":\"2025-04-23T07:35:43+00:00\",\"dateModified\":\"2025-04-23T07:35:45+00:00\",\"description\":\"An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/bio4dreams.com\\\/wp-content\\\/uploads\\\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Investimento CP2 Biotech \\\/ startup \\\/ terapie immunomodulanti\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/investment-cp2biotech-startup-immunomodulatory-therapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bio4dreams.com\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio4Dreams invests in CP2 Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#website\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/\",\"name\":\"Bio4Dreams\",\"description\":\"La Business Nursery per le Scienze della Vita\",\"publisher\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bio4dreams.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#organization\",\"name\":\"Bio4Dreams S.p.A.\",\"url\":\"https:\\\/\\\/bio4dreams.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Bio4Dreams S.p.A.\"},\"image\":{\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Bio4Dreams\\\/\",\"https:\\\/\\\/x.com\\\/bio4dreams\",\"https:\\\/\\\/www.instagram.com\\\/bio4dreams\\\/\",\"https:\\\/\\\/it.linkedin.com\\\/company\\\/bio4dreams\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClKlMPs6Lgd23ZIHlnCI4QA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bio4dreams.com\\\/#\\\/schema\\\/person\\\/9af11b6db87fca29131e5095f3b0e452\",\"name\":\"Bio4Dreams | NS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ed252742ec370eea46b51395e32caa14613fb0b10104cc242035236b258413a6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ed252742ec370eea46b51395e32caa14613fb0b10104cc242035236b258413a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ed252742ec370eea46b51395e32caa14613fb0b10104cc242035236b258413a6?s=96&d=mm&r=g\",\"caption\":\"Bio4Dreams | NS\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio4Dreams invests in CP2 Biotech - Bio4Dreams","description":"An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/","og_locale":"en_US","og_type":"article","og_title":"Bio4Dreams invests in CP2 Biotech - Bio4Dreams","og_description":"An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.","og_url":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/","og_site_name":"Bio4Dreams","article_publisher":"https:\/\/www.facebook.com\/Bio4Dreams\/","article_published_time":"2025-04-23T07:35:43+00:00","article_modified_time":"2025-04-23T07:35:45+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/bio4dreams.com\/wp-content\/uploads\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg","type":"image\/jpeg"}],"author":"Bio4Dreams | NS","twitter_card":"summary_large_image","twitter_creator":"@bio4dreams","twitter_site":"@bio4dreams","twitter_misc":{"Written by":"Bio4Dreams | NS","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#article","isPartOf":{"@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/"},"author":{"name":"Bio4Dreams | NS","@id":"https:\/\/bio4dreams.com\/#\/schema\/person\/9af11b6db87fca29131e5095f3b0e452"},"headline":"Bio4Dreams invests in CP2 Biotech","datePublished":"2025-04-23T07:35:43+00:00","dateModified":"2025-04-23T07:35:45+00:00","mainEntityOfPage":{"@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/"},"wordCount":176,"publisher":{"@id":"https:\/\/bio4dreams.com\/#organization"},"image":{"@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/bio4dreams.com\/wp-content\/uploads\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg","keywords":["Highlights"],"articleSection":["Portfolio"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/","url":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/","name":"Bio4Dreams invests in CP2 Biotech - Bio4Dreams","isPartOf":{"@id":"https:\/\/bio4dreams.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#primaryimage"},"image":{"@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/bio4dreams.com\/wp-content\/uploads\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg","datePublished":"2025-04-23T07:35:43+00:00","dateModified":"2025-04-23T07:35:45+00:00","description":"An investment to support the preclinical development and validation of the startup\u2019s innovative immunomodulatory molecules.","breadcrumb":{"@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#primaryimage","url":"https:\/\/bio4dreams.com\/wp-content\/uploads\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg","contentUrl":"https:\/\/bio4dreams.com\/wp-content\/uploads\/investimento-cp2biotech-startup-terapie-immunomodulanti_1920.jpg","width":1920,"height":1080,"caption":"Investimento CP2 Biotech \/ startup \/ terapie immunomodulanti"},{"@type":"BreadcrumbList","@id":"https:\/\/bio4dreams.com\/en\/investment-cp2biotech-startup-immunomodulatory-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bio4dreams.com\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Bio4Dreams invests in CP2 Biotech"}]},{"@type":"WebSite","@id":"https:\/\/bio4dreams.com\/#website","url":"https:\/\/bio4dreams.com\/","name":"Bio4Dreams","description":"La Business Nursery per le Scienze della Vita","publisher":{"@id":"https:\/\/bio4dreams.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bio4dreams.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bio4dreams.com\/#organization","name":"Bio4Dreams S.p.A.","url":"https:\/\/bio4dreams.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bio4dreams.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Bio4Dreams S.p.A."},"image":{"@id":"https:\/\/bio4dreams.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Bio4Dreams\/","https:\/\/x.com\/bio4dreams","https:\/\/www.instagram.com\/bio4dreams\/","https:\/\/it.linkedin.com\/company\/bio4dreams","https:\/\/www.youtube.com\/channel\/UClKlMPs6Lgd23ZIHlnCI4QA"]},{"@type":"Person","@id":"https:\/\/bio4dreams.com\/#\/schema\/person\/9af11b6db87fca29131e5095f3b0e452","name":"Bio4Dreams | NS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ed252742ec370eea46b51395e32caa14613fb0b10104cc242035236b258413a6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ed252742ec370eea46b51395e32caa14613fb0b10104cc242035236b258413a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ed252742ec370eea46b51395e32caa14613fb0b10104cc242035236b258413a6?s=96&d=mm&r=g","caption":"Bio4Dreams | NS"}}]}},"_links":{"self":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts\/19379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/comments?post=19379"}],"version-history":[{"count":1,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts\/19379\/revisions"}],"predecessor-version":[{"id":19380,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/posts\/19379\/revisions\/19380"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/media\/19384"}],"wp:attachment":[{"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/media?parent=19379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/categories?post=19379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bio4dreams.com\/en\/wp-json\/wp\/v2\/tags?post=19379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}